G protein-coupled estrogen receptor 1 (GPER-1) has gained recognition for its role in conferring cardioprotection. However, the extent to which GPER-1 exerts equally important effects in both sexes remains unclear. The study found similar expressions of GPER-1 in rat heart apex in both sexes. In male rats, administering epinephrine (Epi) at a dose of 31.36 microg/100 g resulted in a rapid decline in cardiac function, accompanied by a sharp increase in bax/bcl-2 levels. In contrast, female rats did not display significant changes in cardiac function under the same conditions. Additionally, compared to the injection of Epi alone (at a dose of 15.68 microg/100 g), the administration of G15 (GPER-1 antagonist) further decreased cardiac function in both male and female rats. However, it only increased mortality and lung coefficient in male rats. Conversely, G1 (GPER-1 agonist) administration improved cardiac function in both sexes. Notably, the apex of the male heart exhibited lower levels of inhibitory G protein (Galphai). Furthermore, female and male rats treated with Epi displayed elevated phosphorylated protein kinase B (p-Akt). Compared to their respective Epi groups, the administration of G15 increased p-Akt levels in female rat hearts but decreased them in male rat hearts. Conversely, the administration of G1 decreased p-Akt levels in females but rapidly increased them in male rats. Our study uncovers the vital role of GPER-1 in protecting against stress-induced heart injuries in a sex-specific manner. These findings hold immense potential for advancing targeted cardiac therapies and enhancing outcomes for both females and males.

Physiology Department Xuzhou Medical University Xuzhou China

Zobrazit více v PubMed

Kittnar O. Sex Related Differences in Electrocardiography. Physiol Res. 2023;72(Suppl 2):S127–S135. doi: 10.33549/physiolres.934952. PubMed DOI PMC

Kuneš J, Hojná S, Mráziková L, Montezano A, Touyz RM, Maletínská L. Obesity, Cardiovascular and Neurodegenerative Diseases: Potential Common Mechanisms. Physiol Res. 2023;72(Suppl 2):S73–S90. doi: 10.33549/physiolres.935109. PubMed DOI PMC

Adu-Amankwaah J, Adzika GK, Adekunle AO, Ndzie Noah ML, Mprah R, Bushi A, Akhter N, et al. The Synergy of ADAM17-Induced Myocardial Inflammation and Metabolic Lipids Dysregulation During Acute Stress: New Pathophysiologic Insights Into Takotsubo Cardiomyopathy. Front Cardiovasc Med. 2021;8:696413. doi: 10.3389/fcvm.2021.696413. PubMed DOI PMC

Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci. 2004;25:358–365. doi: 10.1016/j.tips.2004.05.007. PubMed DOI

Adu-Amankwaah J, Adzika GK, Adekunle AO, Ndzie Noah ML, Mprah R, Bushi A, et al. ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress. Front Cell Dev Biol. 2021;9:732952. doi: 10.3389/fcell.2021.732952. PubMed DOI PMC

Adu-Amankwaah J. “Happy Heart” Versus “Broken Heart” Syndrome: The 2 Faces of Takotsubo Syndrome: Similarities and Differences. JACC Heart Fail. 2022;10:467–469. doi: 10.1016/j.jchf.2022.02.016. PubMed DOI

Nef HM, Möllmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010;7:187–193. doi: 10.1038/nrcardio.2010.16. PubMed DOI

Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med. 2008;5:22–29. doi: 10.1038/ncpcardio1066. PubMed DOI

Adu-Amankwaah J, Bushi A, Tan R, Adekunle AO, Adzika GK, Ndzie Noah ML, Nadeem I, et al. Estradiol mitigates stress-induced cardiac injury and inflammation by downregulating ADAM17 via the GPER-1/PI3K signaling pathway. Cell Mol Life Sci. 2023;80:246. doi: 10.1007/s00018-023-04886-6. PubMed DOI PMC

Adzika GK, Machuki JO, Shang W, Hou H, Ma T, Wu L, Geng J, et al. Pathological cardiac hypertrophy: the synergy of adenylyl cyclases inhibition in cardiac and immune cells during chronic catecholamine stress. J Mol Med (Berl) 2019;97:897–907. doi: 10.1007/s00109-019-01790-0. PubMed DOI

Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O’Gara P, Stuckey DJ, et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126:697–706. doi: 10.1161/CIRCULATIONAHA.112.111591. PubMed DOI PMC

Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007;67:1859–1866. doi: 10.1158/0008-5472.CAN-06-2909. PubMed DOI

Azizian H, Khaksari M, Asadi Karam G, Esmailidehaj M, Farhadi Z. Cardioprotective and anti-inflammatory effects of G-protein coupled receptor 30 (GPR30) on postmenopausal type 2 diabetic rats. Biomed Pharmacother. 2018;108:153–164. doi: 10.1016/j.biopha.2018.09.028. PubMed DOI

Wang X, Lu L, Tan Y, Jiang L, Zhao M, Gao E, Yu S, Liu J. GPR 30 reduces myocardial infarct area and fibrosis in female ovariectomized mice by activating the PI3K/AKT pathway. Life Sci. 2019;226:22–32. doi: 10.1016/j.lfs.2019.03.049. PubMed DOI

Pillerová M, Pastorek M, Borbélyová V, Riljak V, Frick KM, Hodosy J, Tóthová L. Sex steroid hormones in depressive disorders as a basis for new potential treatment strategies. Physiol Res. 2022;71(Suppl 2):S187–S202. doi: 10.33549/physiolres.935001. PubMed DOI PMC

Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol. 2009;297:H1806–H1813. doi: 10.1152/ajpheart.00283.2009. PubMed DOI PMC

Fu L, Zhang H, Ong’achwa Machuki J, Zhang T, Han L, Sang L, Wu L, et al. GPER mediates estrogen cardioprotection against epinephrine-induced stress. J Endocrinol. 2021;249:209–222. doi: 10.1530/JOE-20-0451. PubMed DOI

Fu L, Adu-Amankwaah J, Sang L, Tang Z, Gong Z, Zhang X, Li T, Sun H. Gender differences in GRK2 in cardiovascular diseases and its interactions with estrogen. Am J Physiol Cell Physiol. 2023;324:C505–C516. doi: 10.1152/ajpcell.00407.2022. PubMed DOI

Kang S, Liu Y, Sun D, Zhou C, Liu A, Xu C, Hao Y, Li D, Yan C, Sun H. Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure. PLoS One. 2012;7:e48185. doi: 10.1371/journal.pone.0048185. PubMed DOI PMC

Cao X, Zhou C, Chong J, Fu L, Zhang L, Sun D, Hou H, et al. Estrogen resisted stress-induced cardiomyopathy through increasing the activity of β-AR-Gαs signal pathway in female rats. Int J Cardiol. 2015;187:377–386. doi: 10.1016/j.ijcard.2015.02.113. PubMed DOI

Haas E, Bhattacharyal I, Brailoiu E, Damjanović M, Cristina Brailoiu G, Gao X, Mueller-Guerre L, et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res. 2009;104:288–291. doi: 10.1161/CIRCRESAHA.108.190892. PubMed DOI PMC

Filice E, Recchia AG, Pellegrino D, Angelone T, Maggiolini M, Cerra MC.A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat J Physiol Pharmacol 2009603–10.. PubMed

Glaveckaitė S, Šerpytis P, Pečiūraitė D, Puronaitė R, Valevičienė N. Clinical features and three-year outcomes of Takotsubo (stress) cardiomyopathy: Observational data from one center. Hellenic J Cardiol. 2016;57:428–434. doi: 10.1016/j.hjc.2016.11.016. PubMed DOI

Chaanine AH, Hajjar RJ. AKT signalling in the failing heart. Eur J Heart Fail. 2011;13:825–829. doi: 10.1093/eurjhf/hfr080. PubMed DOI PMC